|
|
Article: FDA's proposed OTC drug labeling shouldn't spur big changes
- Article from:
- Dermatology Times
- Article date:
- February 1, 1998
- Author:
CopyrightCopyright Advanstar Communications, Inc. Feb 1998. Provided by ProQuest LLC. (Hide copyright information)
|
WASHINGTON, DC-Will proposed FDA labeling requirements for overthe-counter (OTC) drugs affect marketing and patient use of dermatologic OTC drug products?
The potential changes, introduced mainly to increase the readability and understanding of instructions for consumer safety, should be a boon to patient and practitioner alike, but not much is likely to change, according to a few veteran dermatologists.
"Offering patients a clear view of benefits versus risks on every bottle makes my job easier," explained William Coleman III, MD, clinical professor of dermatology at Tulane University School of Medicine, New Orleans, and vice president of the American Society for Dermatologic Surgery.
...